(1H-Indazol-5-yl)methanamine hydrochloride, 95.0%, 1g

2-Amino-4,5-dimethyl-1-(2,4,6-trimethyl-phenyl)-1H-pyrrole-3-carbonitrile, 95.0%, 5g

Fasiglifam, 98.94%, 25mg

2,3-dimethyl-4'-methoxybenzophenone, 97.0%, 1g

N-Isopropylaminoacetic acid ethyl esterhydrochloride, 98.0%, 5g

5-Bromo-2-isopropoxyisonicotinaldehyde, 97%, 1g

5-Bromo-N-ethylnicotinamide, 95.0%, 5g

2-Amino-9,9-diphenylfluorene>98.0%(HPLC)(T)5g

(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol, 98%, 1g

2-(5-Hydroxypyridin-2-yl)acetic acid, 95%, 10g

Methyl 5-cyano-2-methylbenzoate, 97%, 5g

2H-Indazole, 2-[(2-chloro-4-fluorophenyl)Methyl]-3-(4-fluorophenyl)-7-(trifluoroMethyl)-, 1mg

Methyl (2S,4R)-4-hydroxypyrrolidine-2-carboxylate hydrochloride, 97.0%, 100g